Skip to main content
. 2012 May 9;7(5):e36345. doi: 10.1371/journal.pone.0036345

Table 5. Regression coefficients (β) for relationships between Actigraph-derived and IPAQ-reported MVPA and vascular and metabolic risk factors.

Outcome MVPA – Accelerometer MVPA – IPAQ
β (95%CI) p β (95%CI) p p-interaction
Glucose (mmol.l−1) −0.08 (−0.2 to −0.04) 0.021 −0.1 (−0.2 to −0.01) 0.037 0.305
Insulin (mU.l−1) −2.8 (−4.2 to −1.4) <0.0001 −1.9 (−3.4 to −0.5) 0.010 0.002
HOMAIR −0.6 (−0.8 to 0.3) <0.0001 −0.4 (−0.7 to −0.2) 0.002 <0.0001
Total Cholesterol (mmol.l−1) −0.11 (−0.23 to −0.02) 0.011 −0.06 (−0.19 to −0.07) 0.388 0.102
HDL cholesterol (mmol.l−1) 0.07 (0.03 to 0.11) 0.001 0.02 (−0.21 to 0.07) 0.311 0.261
LDL cholesterol (mmol.l−1) −0.14 (−0.27 to −0.01) 0.042 −0.06 (−0.20 to 0.08) 0.403 0.181
Triglyceride (mmol.l−1) −0.07 (−0.13 to −0.02) 0.035 −0.04 (−0.11 to 0.02) 0.188 0.011
Systolic BP (mm Hg) −1.4 (−3.1 to 0.1) 0.070 −1.6 (−3.2 to 0.04) 0.056 0.084
Diastolic BP (mm Hg) −0.1 (−1.3 to 1.1) 0.887 0.1 (−1.2 to 1.4) 0.870 0.061
Body Mass Index (m.kg−2) −0.2 (−0.7 to −0.1) 0.023 −0.3 (−0.8 to 0.2) 0.188 0.448
Waist Circumference (cm) −0.6 (−2.0 to −0.7) 0.036 −1.1 (−2.5 to 0.3) 0.130 0.258
Body Fat (%) −1.5 (−1.6 to −0.5) <0.0001 −0.5 (−1.1 to 0.01) 0.055 0.138

N = 317. Data presented as β coefficient and 95%CI for change in risk factor per 100-MET.min change in MVPA, adjusted for age, sex, ethnicity, environment and socio-economic status and smoking. P-values values are given for β values for each measurement method and for the interaction between regression coefficients derived from accelerometer vs IPAQ measurements.